1786
vs
T
Taiwan Weighted Index
1786
Over the past 12 months, SciVision Biotech Inc has underperformed Taiwan Weighted Index, delivering a return of -40% compared to the Taiwan Weighted Index's +56% growth.
Stocks Performance
1786 vs Taiwan Weighted Index
Performance Gap
1786 vs Taiwan Weighted Index
Performance By Year
1786 vs Taiwan Weighted Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
SciVision Biotech Inc
Glance View
SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.
